IRIS
PIETRA, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.790
AS - Asia 1.140
NA - Nord America 941
Continente sconosciuto - Info sul continente non disponibili 185
SA - Sud America 93
AF - Africa 19
OC - Oceania 1
Totale 13.169
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 10.583
US - Stati Uniti d'America 885
SG - Singapore 471
CN - Cina 313
VN - Vietnam 209
FR - Francia 80
BD - Bangladesh 60
BR - Brasile 52
FI - Finlandia 40
HK - Hong Kong 32
DE - Germania 26
AR - Argentina 17
CA - Canada 17
JP - Giappone 17
GB - Regno Unito 16
MX - Messico 10
CH - Svizzera 9
CO - Colombia 8
IN - India 8
ZA - Sudafrica 8
CR - Costa Rica 7
IQ - Iraq 7
RU - Federazione Russa 7
EC - Ecuador 6
JM - Giamaica 6
GT - Guatemala 5
HN - Honduras 5
NL - Olanda 4
PL - Polonia 4
BB - Barbados 3
ES - Italia 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AT - Austria 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GY - Guiana 2
IL - Israele 2
MA - Marocco 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
SE - Svezia 2
SI - Slovenia 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
EG - Egitto 1
ET - Etiopia 1
HU - Ungheria 1
ID - Indonesia 1
IE - Irlanda 1
IR - Iran 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 12.984
Salva come PNG Salva come JPEG
Città #
Genova 6.456
Genoa 2.456
Vado Ligure 811
Rapallo 760
San Jose 222
Singapore 215
Ashburn 123
Lauterbourg 76
Ho Chi Minh City 50
Hanoi 45
Council Bluffs 43
Beijing 41
Helsinki 40
Hong Kong 32
New York 28
Frankfurt am Main 21
Santa Clara 17
Tokyo 16
Da Nang 13
Los Angeles 13
Milan 13
Buffalo 11
Tianjin 10
Houston 9
Rome 9
Zurich 9
Dallas 8
Haiphong 8
Mexico City 8
Las Vegas 7
Brooklyn 6
Des Moines 6
Hải Dương 6
Bordighera 5
Florence 5
Johannesburg 5
London 5
Naples 5
San José 5
St Louis 5
São Paulo 5
Biên Hòa 4
Chicago 4
City of London 4
Kingston 4
Montreal 4
Nuremberg 4
Princeton 4
Queens 4
Quảng Ngãi 4
Washington 4
Alexandria 3
Amsterdam 3
Atlanta 3
Baghdad 3
Boydton 3
Charlotte 3
Guatemala City 3
Jacksonville 3
Janesville 3
Kansas City 3
Lafayette 3
Newark 3
Orem 3
Orlando 3
Paris 3
Pasadena 3
Philadelphia 3
Phủ Lý 3
Pisa 3
Quito 3
San Pedro Sula 3
Savannah 3
Toronto 3
Turin 3
Anderson 2
Baldwin Park 2
Baltimore 2
Blythewood 2
Bogotá 2
Bologna 2
Bridgetown 2
Bắc Ninh 2
Calexico 2
Campinas 2
Can Tho 2
Catania 2
Chennai 2
Cleveland 2
Dearborn Heights 2
Denver 2
Durban 2
Erbil 2
Fortaleza 2
Georgetown 2
Go Vap 2
Greenville 2
Guayaquil 2
Helotes 2
Hope Mills 2
Totale 11.790
Salva come PNG Salva come JPEG
Nome #
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 265
Identification of cytomegalovirus (CMV)-specific T lymphocytes displaying an effector-memory phenotype that kill CMV-infected target cells in an HLA-E-restricted fashion 260
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function 221
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 210
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 200
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 199
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 199
Effect of tumor cells and tumor microenvironment on NK-cell function. 193
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK cell function 192
Detection of MAGE-1, -2, and -3 messenger RNA in tissue samples derived from lung and mammary tumors. 183
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 183
Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts 182
Detection of oligoclonal T lymphocytes in lymph nodes draining from advanced non-small-cell lung cancer. 180
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition 177
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 173
Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells. 173
alpha-Interferon treatment induces quantitative modifications of HLA class I-associated peptides eluted from cultured cancer cell lines 171
HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition 170
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients. 165
Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells 161
Analysis of the proliferative and phenotypic properties of tumor infiltrating lymphocytes expanded in vitro in the course of the clinical trial of adoptive immunotherapy of metastatic melanoma. 159
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 157
A conserved energetic footprint underpins recognition of Human Leukocyte Antigen-E by two distinct αβ T cell receptors 156
A new mechanism of resistance to NK cell attack in melanoma 153
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. 152
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells 151
Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot study. 150
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? 150
Effect of Melanoma-derived Fibroblasts on NK Cell Phenotype and Functions 148
Hypoxia modifies the transcriptome of human NK cells, modulates their immunoregulatory profile, and influences NK cell subset migration 147
L19-IL2 immunocytokine in combination with the anti-syndecan-1 46F2SIP antibody format: A new targeted treatment approach in an ovarian carcinoma model 146
Structural basis for a major histocompatibility complex class Ib-restricted T cell response 145
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors. 145
Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. 144
Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E 144
Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically. 143
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation 143
How melanoma cells inactivate NK cells 142
Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines 142
HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes 142
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 142
Role of NK cells in immunotherapy and virotherapy of solid tumors 141
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC. 141
Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. 139
Natural killer cells kill human melanoma cells with characteristics of cancer stem cells. 138
NK-CTLs, a novel HLA-E-restricted T-cell subset 137
EXPRESSION OF KILLER INHIBOTORY RECEPTOR (KIR) CD158B ON RESIDUAL TCRalpha/beta or gamma/delta T CELLS ON B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL) MODULATE THEIR CYTOTOXIC ACTIVITY 136
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. 135
Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines. 133
Isolation, Expansion, and Characterization of Natural Killer Cells and Their Precursors as a Tool to Study Cancer Immunosurveillance 133
Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board 131
Characterization of metabolic and molecular response of a human melanoma cell line resistant to PLX4032 131
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition 130
Quantitative flow cytometric analysis of the effects of cetirizine on the expression of ICAM-1/CD54 on primary cultured nasal cells. 130
Human NK cells: From surface receptors to clinical applications 130
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity 128
PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism 127
Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2 126
Melanoma immunoediting by NK cells. 126
Dendritic cell maturation is inhibited by apoptotic bodies and promoted by necrotic cells from human melanoma 125
Melanoma cells inhibit NK cell functions-response 122
Morphological, phenotypic and karyotypic characterization of a novel natural-killer-cell target - evidence of involvement of MHC class-I molecules in NK cell recognition. 121
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori Group. 120
Normal epithelial cells modulating HLA class I surface molecules are susceptible to lysis mediated by CD3(+) and CD3(-) "nonspecific" killer cells. 117
Exploiting Human NK Cells in Tumor Therapy 117
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting 116
Limiting dilution analysis of peripheral blood lymphocytes reacting with non-small-cell lung cancer: functionally heterogeneous effectors efficiently lyse autologous cancer cells. 115
Heterogeneity of the alpha-interferon-mediated overexpression of class-I and class-II major histocompatibility complex molecules in primary cultured cancer cells. 113
Human NK cells and cancer 112
MELANOMA CELLS INTERFERE WITH THE ACTIVITY OF NK CELLS BY MODULATING THEIR PHENOTYPE AND CYTOTOXIC FUNCTION 112
Hla-E-Restricted Cytolytic T Lymphocytes: Their Role in Cytomegalovirus Infection and Transplantation 110
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells. 110
Murine models to study human NK cells in human solid tumors 108
Melanoma cells inhibit natural killer cell function by modulating their phenotype 108
Natural Killer Cell Effector Mechanisms Against solid tumors and leukemias and their exploitation in immunotherapy 105
Human cytolytic T lymphocytes expressing HLA class I-specific inhibitory receptors 103
Phenotipic and Functional Characterization of Human Decidual Natural Killer Cells 102
NK CELL AND TUMOR MICROENVIRONMENT INTERACTIONS IN MELANOMA 100
Recognition of the non-classical MHC class I molecule, HLA-E, by the adaptive immune system 97
Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzymes peroxiredoxin 5 92
HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia 91
The engagement of ctla-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and tnf-alpha production. 90
Guadecitabine impact on phenotype and function of peripheral blood and hematopoietic stem cell-derived NK: in vitro differentiation and proliferation 88
In vitro effects of loratadine and its active metabolite an T lymphocytes 88
Interleukin-15 and cancer: Some solved and many unsolved questions 87
RECOGNITION OF HLA-E BY NATURAL KILLER CELLS IS IMPACTED BY VARIATION IN CYTOMEGALOVIRUS UL40 SEQUENCES IN HAEMOPOIETIC STEM CELL TRANSPLANTATION 86
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 86
Human dendritic cells (DCs) efficiently internalize apoptotic bodies from vaccinia virus infected non Hodgkin lymphoma (NHL) cells. 85
The role of peptide in the recognition of HLA-E by cytomegalovirus-specific CD8+T cells 84
Polymorphism in human cytomegalovirus UL40 impacts on recognition of HLA-E by natural killer cells. 84
NK cells and ILCs in tumor immunotherapy 84
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy 84
Targeted therapies: Friends or foes for patient's NK cell-mediated tumor immune-surveillance? 82
Titolo BOOK Chapter: NK cell effector mechanisms against solid tumors and leukemias and their exploitation in immunotherapy. Cancer Immunotherapy Principles and Practice, edited by Lisa H. Butterfield, PhD, Howard L. Kaufman, MD, FACS, and Francesco M. Marincola, MD, FACS, (Volume Editors). 75
Vitamin D plasma level can affect nivolumab drug exposure in a cohort of patients with non-small-cell lung cancer 74
Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells. 65
The roles of different forms of IL-15 in human melanoma progression 63
Natural killer cell receptors regulate responses of HLA-E-restricted T cells 50
TIGIT Blockade and IL15 in Tumor Immunotherapy: Together is Better 48
Totale 13.169
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.607
article - articoli 39.338
book - libri 349
conference - conferenze 225
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 695
Totale 81.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.072 16 81 87 96 47 76 73 261 59 104 47 125
2022/2023918 99 56 13 78 176 168 0 66 155 3 89 15
2023/2024535 30 62 18 84 61 104 21 20 20 17 22 76
2024/20251.810 37 121 66 89 335 213 211 219 76 99 143 201
2025/20262.945 330 114 174 229 395 279 459 201 211 276 121 156
2026/2027341 341 0 0 0 0 0 0 0 0 0 0 0
Totale 13.169